Cargando…

Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis

BACKGROUND: Recent years have seen important improvements in available preventive treatment regimens for tuberculosis (TB), and research is ongoing to develop these further. To assist with the formulation of target product profiles for future regimens, we examined which regimen properties would be m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vesga, Juan F., Lienhardt, Christian, Nsengiyumva, Placide, Campbell, Jonathon R., Oxlade, Olivia, den Boon, Saskia, Falzon, Dennis, Schwartzman, Kevin, Churchyard, Gavin, Arinaminpathy, Nimalan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115962/ https://www.ncbi.nlm.nih.gov/pubmed/35581650 http://dx.doi.org/10.1186/s12916-022-02378-1

Ejemplares similares

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2022)

Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2018)

WHO target product profiles for TB preventive treatment
por: Den Boon, S., et al.
Publicado: (2022)

The impact of digital health technologies on tuberculosis treatment: a systematic review
por: Ngwatu, Brian Kermu, et al.
Publicado: (2018)

The potential impact and cost-effectiveness of tobacco reduction strategies for tuberculosis prevention in Canadian Inuit communities
por: N’Diaye, Dieynaba S., et al.
Publicado: (2019)

Social and behavioral risk reduction strategies for tuberculosis prevention in Canadian Inuit communities: a cost-effectiveness analysis
por: Uppal, Aashna, et al.
Publicado: (2021)

Triage of Persons With Tuberculosis Symptoms Using Artificial Intelligence–Based Chest Radiograph Interpretation: A Cost-Effectiveness Analysis
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2021)

Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis
por: Yanes-Lane, Mercedes, et al.
Publicado: (2021)

Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
por: Campbell, Jonathon R., et al.
Publicado: (2022)

Framework for the evaluation of new tests for tuberculosis infection
por: Hamada, Yohhei, et al.
Publicado: (2021)

The mTST – An mHealth approach for training and quality assurance of tuberculin skin test administration and reading
por: Moayedi-Nia, Saeedeh, et al.
Publicado: (2019)

Tuberculosis preventive treatment in people living with HIV—Is the glass half empty or half full?
por: Oxlade, Olivia, et al.
Publicado: (2021)

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
por: Kendall, Emily A., et al.
Publicado: (2017)

The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis
por: Ricks, Saskia, et al.
Publicado: (2020)

Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis
por: Uppal, Aashna, et al.
Publicado: (2021)

The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2021)

Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
por: Weyer, Karin, et al.
Publicado: (2018)

Management of tuberculosis by healthcare practitioners in Pakistan: A systematic review
por: Braham, Christy A., et al.
Publicado: (2018)

Global reporting on tuberculosis preventive treatment among contacts
por: Falzon, Dennis, et al.
Publicado: (2022)

The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study
por: Romanowski, Kamila, et al.
Publicado: (2019)

The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis
por: Cilloni, Lucia, et al.
Publicado: (2020)

Dynamics of Glycoprotein Charge in the Evolutionary History of Human Influenza
por: Arinaminpathy, Nimalan, et al.
Publicado: (2010)

The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis
por: Arinaminpathy, Nimalan, et al.
Publicado: (2020)

The Global Drug Facility as an intervention in the market for tuberculosis drugs
por: Arinaminpathy, Nimalan, et al.
Publicado: (2015)

Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis
por: Silva, Sachin, et al.
Publicado: (2021)

Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2022)

Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis
por: Cilloni, Lucia, et al.
Publicado: (2020)

Explaining age disparities in tuberculosis burden in Taiwan: a modelling study
por: Fu, Han, et al.
Publicado: (2020)

Building a tuberculosis-free world while responding to the COVID-19 pandemic
por: Reid, Michael J A, et al.
Publicado: (2020)

Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review
por: Chimoyi, Lucy Andere, et al.
Publicado: (2020)

Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
por: Tseng, Chia-Lin, et al.
Publicado: (2011)

The potential impact of vaccination on tuberculosis burden in India: A modelling analysis
por: Arinaminpathy, Nimalan, et al.
Publicado: (2023)

Predicting the impact of patient and private provider behavior on diagnostic delay for pulmonary tuberculosis patients in India: A simulation modeling study
por: Deo, Sarang, et al.
Publicado: (2020)

Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccine
por: Fu, Han, et al.
Publicado: (2021)

Xpert®MTB/RIF for the Diagnosis of Tuberculosis in a Remote Arctic Setting: Impact on Cost and Time to Treatment Initiation
por: Oxlade, Olivia, et al.
Publicado: (2016)

A clinical scoring system to prioritise investigation for tuberculosis among adults attending HIV clinics in South Africa
por: Hanifa, Yasmeen, et al.
Publicado: (2017)

The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach
por: Mandal, Sandip, et al.
Publicado: (2020)

fastlin: an ultra-fast program for Mycobacterium tuberculosis complex lineage typing
por: Derelle, Romain, et al.
Publicado: (2023)

COVID-19 Vaccine Prioritisation for Medical Students: The Forgotten Cohort?
por: Lim, J.S., et al.
Publicado: (2021)

The effects of a partitioned var gene repertoire of Plasmodium falciparum on antigenic diversity and the acquisition of clinical immunity
por: Recker, Mario, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_v2rnqr1ksegosb4um5eccqj84t